Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: sulfobutyl ether beta-cyclodextrin

April 10, 2026 Analysis / Pharma applications

Continuous chiral CPC in practice: Process intensification for voriconazole enantioseparation

A recent study from RotaChrom Technologies shows that continuous chiral separation by centrifugal partition chromatography (CPC) can be achieved for

Continue reading

October 6, 2021 Drug delivery / Pharma applications

Aggregation versus inclusion complexes to solubilize drugs with cyclodextrins. A case study using sulfobutylether-β-cyclodextrins and remdesivir

Using MD simulations, the possible role of SBE-β-CDs aggregates in the solubilization of remdesivir was studied. Both the effect of

Continue reading

August 26, 2021 CD as API / CD derivatives / Pharma applications

Aequus and reVision to Collaborate on Stargardt Disease Program using SBECD as active

Aequus Pharmaceuticals Inc. and reVision Therapeutics, Inc. (“reVision”) announced a collaboration on the development of a therapy for Stargardt disease.

Continue reading

October 7, 2020 Drug delivery / Pharma applications

Inclusion complex of chrysin with sulfobutyl ether-β-cyclodextrin

The work of Kulkarni and Belgamvar [1] demonstrates the impact of sulfobutyl ether-β-cyclodextrin (SBE-β-CD) complexation on the solubility, dissolution and

Continue reading

Recent Posts

  • HUPHAR 2027
  • Cyclodextrins Target Inflammatory Foam Cells in Multiple Sclerosis Lesions
  • FDA Approves LEMBAZ for Infantile-Onset Niemann-Pick Disease
  • HPBCD beads for drug delivery
  • FDA Clears Cyclarity’s UDP-003 Trial for Heart Disease

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (28)
  • Analysis (75)
  • CD as API (364)
  • CD derivatives (447)
  • Cosmetics and toilettry (55)
  • Diagnosis (15)
  • Drug delivery (835)
  • E-ducation (64)
  • Environmental (144)
  • Events (244)
  • Food (239)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (46)
  • Non-pharma applications (429)
  • Other industrial use (115)
  • Pharma applications (1,247)
  • Supramolecular systems (45)
  • Uncategorized (178)

Top Posts

  • Cyclodextrins Target Inflammatory Foam Cells in Multiple Sclerosis Lesions
  • FDA Approves LEMBAZ for Infantile-Onset Niemann-Pick Disease
  • HUPHAR 2027
  • MIT scientists filed patent for HPBCD treatment in Alzheimer's disease
  • HPBCD beads for drug delivery
  • Special Issue of the journal Materials "Cyclodextrin-Based Nanomaterials: Synthesis, Properties, and Applications”
  • Chlorine dioxide in α-cyclodextrin as food preservative
  • Low sulfur biodiesel produced from sewage enabled by beta-cyclodextrin
  • Honoring Professor Tsuneji Nagai
  • FDA Clears Cyclarity’s UDP-003 Trial for Heart Disease

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,472 other subscribers
Loading Comments...